AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,856,645 | -10.2% | 298,421 | -7.7% | 0.00% | 0.0% |
| Q2 2023 | $23,233,560 | -15.9% | 323,317 | -27.8% | 0.00% | -33.3% |
| Q1 2023 | $27,618,577 | -25.0% | 447,772 | -6.2% | 0.00% | -25.0% |
| Q4 2022 | $36,810,756 | +37.6% | 477,256 | -20.4% | 0.00% | 0.0% |
| Q3 2022 | $26,752,000 | +78.2% | 599,531 | +52.9% | 0.00% | +100.0% |
| Q2 2022 | $15,013,000 | +57.1% | 391,986 | +69.8% | 0.00% | +100.0% |
| Q1 2022 | $9,557,000 | +43.0% | 230,912 | +30.5% | 0.00% | 0.0% |
| Q4 2021 | $6,682,000 | -44.6% | 176,896 | -51.7% | 0.00% | -50.0% |
| Q3 2021 | $12,062,000 | -43.7% | 365,969 | +15.3% | 0.00% | -33.3% |
| Q2 2021 | $21,414,000 | +165.5% | 317,446 | +122.8% | 0.00% | +200.0% |
| Q1 2021 | $8,066,000 | +102.2% | 142,466 | +191.0% | 0.00% | 0.0% |
| Q4 2020 | $3,989,000 | +32.8% | 48,961 | +16.1% | 0.00% | 0.0% |
| Q3 2020 | $3,004,000 | -19.7% | 42,175 | -7.3% | 0.00% | 0.0% |
| Q2 2020 | $3,741,000 | -30.7% | 45,479 | -50.4% | 0.00% | 0.0% |
| Q1 2020 | $5,397,000 | -7.3% | 91,731 | +62.8% | 0.00% | 0.0% |
| Q4 2019 | $5,824,000 | +211.9% | 56,352 | -38.9% | 0.00% | – |
| Q3 2019 | $1,867,000 | +247.7% | 92,242 | +341.6% | 0.00% | – |
| Q2 2019 | $537,000 | -58.4% | 20,886 | -77.0% | 0.00% | – |
| Q1 2019 | $1,290,000 | +7488.2% | 90,683 | +1399.6% | 0.00% | – |
| Q4 2018 | $17,000 | -29.2% | 6,047 | -13.7% | 0.00% | – |
| Q3 2018 | $24,000 | -17.2% | 7,010 | -22.2% | 0.00% | – |
| Q2 2018 | $29,000 | +31.8% | 9,010 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | -33.3% | 9,010 | +52.5% | 0.00% | – |
| Q4 2017 | $33,000 | +50.0% | 5,910 | +47.4% | 0.00% | – |
| Q3 2017 | $22,000 | -12.0% | 4,010 | -10.4% | 0.00% | – |
| Q2 2017 | $25,000 | -81.3% | 4,473 | -87.1% | 0.00% | – |
| Q1 2017 | $134,000 | -80.2% | 34,606 | -65.5% | 0.00% | – |
| Q4 2016 | $676,000 | +293.0% | 100,316 | +359.5% | 0.00% | – |
| Q3 2016 | $172,000 | -61.7% | 21,831 | -63.4% | 0.00% | – |
| Q2 2016 | $449,000 | +164.1% | 59,617 | +203.0% | 0.00% | – |
| Q1 2016 | $170,000 | +165.6% | 19,673 | +186.4% | 0.00% | – |
| Q4 2015 | $64,000 | – | 6,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |